SCHEMBL11368649

SCHEMBL11368649

CS(=O)(=O)Nc1ncc(SCc2ccccc2)s1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.56
CCNE1 P24864 11/20 0.52
CDK2 P24941 11/20 0.52
CCNE2 O96020 10/20 0.52
LMNA P02545 1/20 0.49
HSD17B10 Q99714 1/20 0.49
CA1 P00915 4/20 0.45
CDK5 Q00535 1/20 0.45
CA12 O43570 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
CDK4 P11802 4/20 0.45
CCND1 P24385 4/20 0.45
CCNB2 O95067 2/20 0.45
CDK1 P06493 2/20 0.45
CCNB1 P14635 2/20 0.45
CCNB3 Q8WWL7 2/20 0.45
KDR P35968 2/20 0.44
CXCR2 P25025 1/20 0.43
CCND2 P30279 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27174843 0.73 CA1 (0.58) GRM4CCNE1CDK2CCNE2HSD17B10
SCHEMBL10009293 0.73 GRM4 (0.65) GRM4CCNE1CDK2CCNE2CDK5
SCHEMBL22867203 0.71 GRM4 (0.54) GRM4CCNE1CDK2CCNE2LMNA
SCHEMBL9045524 0.71 CCNE1 (0.37) GRM4CCNE1CDK2CCNE2LMNA
SCHEMBL958320 0.71 FBP1 (0.64) GRM4CCNE1CDK2CCNE2
SCHEMBL31482769 0.70 GRM4 (0.47) GRM4CCNE1CDK2CCNE2LMNA
SCHEMBL956877 0.70 GRM4 (0.49) GRM4CDK2HSD17B10CA1CA12
SCHEMBL27174928 0.70 GRM4 (0.49) GRM4CCNE1CDK2CCNE2LMNA
SCHEMBL27174952 0.70 GRM4 (0.52) GRM4CCNE1CDK2CCNE2LMNA
SCHEMBL27174839 0.70 GRM4 (0.46) GRM4CCNE1CDK2CCNE2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4254260-A 3-Substituted-7-substituted alkanamido-3-cephem-4-carboxylic acid compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-03-03 US disclosed